Literature DB >> 24083739

Risk factors for early and late intrahepatic recurrence in patients with single hepatocellular carcinoma without macrovascular invasion after curative resection.

Shu-Hong Li1, Zhi-Xing Guo, Cheng-Zuo Xiao, Wei Wei, Ming Shi, Zhi-Yuan Chen, Mu-Yan Cai, Lie Zheng, Rong-Ping Guo.   

Abstract

BACKGROUND: Prognostic factors of postoperative early and late recurrence in patients with hepatocellular carcinoma (HCC) undergoing curative resection remain to be clarified. The aim of this study was to identify risk factors for postoperative early (≤ 2 year) and late (> 2 year) intrahepatic recurrences in patients with single HCCs without macrovascular invasion.
METHODS: A total of 280 patients from December 2004 to December 2007 were retrospectively included in this study. Intrahepatic recurrence was classified into early (≤ 2 year) and late (> 2 year) and the Chi-Square test or Fisher's exact test and multivariate logistic regression analysis were performed to determine significant risk factors.
RESULTS: During the follow-up, 124 patients had intrahepatic recurrence, early and late in 82 and 42 patients, respectively. Multivariate logistic regression analysis showed that microvascular invasion (p=0.006, HR: 2.397, 95% CI: 1.290-4.451) was the only independent risk factor for early recurrence, while being female (p = 0.031, HR: 0.326, 95% CI: 0.118-0.901), and having a high degree of cirrhosis (P=0.001, HR: 2.483, 95% CI: 1.417-4.349) were independent risk factors for late recurrence.
CONCLUSIONS: Early and late recurrence of HCC is linked to different risk factors in patients with single HCC without macrovascular invasion. This results suggested different emphases of strategies for prevent of recurrence after curative resection, more active intervention including adjuvant therapy, anti-cirrhosis drugs and careful follow-up being necessary for patients with relevant risk factors.

Entities:  

Mesh:

Year:  2013        PMID: 24083739     DOI: 10.7314/apjcp.2013.14.8.4759

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  22 in total

1.  2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

Review 2.  Adjuvant and chemopreventive therapies for resectable hepatocellular carcinoma: a literature review.

Authors:  Jian-Hong Zhong; Qing-Lian Zhong; Le-Qun Li; Hang Li
Journal:  Tumour Biol       Date:  2014-08-14

Review 3.  Hepatitis B viral load affects prognosis of hepatocellular carcinoma.

Authors:  Su Jong Yu; Yoon Jun Kim
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 4.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

5.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2019-05-15       Impact factor: 4.519

6.  Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis.

Authors:  Lan-Qing Yao; Zheng-Liang Chen; Zi-Han Feng; Yong-Kang Diao; Chao Li; Hai-Ying Sun; Jian-Hong Zhong; Ting-Hao Chen; Wei-Min Gu; Ya-Hao Zhou; Wan-Guang Zhang; Hong Wang; Yong-Yi Zeng; Han Wu; Ming-Da Wang; Xin-Fei Xu; Timothy M Pawlik; Wan Yee Lau; Feng Shen; Tian Yang
Journal:  Ann Surg Oncol       Date:  2022-02-22       Impact factor: 5.344

7.  Contrast-enhanced ultrasound-based ultrasomics score: a potential biomarker for predicting early recurrence of hepatocellular carcinoma after resection or ablation.

Authors:  Hui Huang; Si-Min Ruan; Meng-Fei Xian; Ming-de Li; Mei-Qing Cheng; Wei Li; Yang Huang; Xiao-Yan Xie; Ming-de Lu; Ming Kuang; Wei Wang; Hang-Tong Hu; Li-Da Chen
Journal:  Br J Radiol       Date:  2021-11-29       Impact factor: 3.039

8.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

9.  Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion.

Authors:  Han Wang; Peng-Cheng Du; Meng-Chao Wu; Wen-Ming Cong
Journal:  Hepatobiliary Surg Nutr       Date:  2018-12       Impact factor: 7.293

10.  Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver disease.

Authors:  Ji Hae Nahm; Hye Sun Lee; Haeryoung Kim; Sun Young Yim; Ji-Hyun Shin; Jeong Eun Yoo; Sang Hoon Ahn; Jin Sub Choi; Ju-Seog Lee; Young Nyun Park
Journal:  Liver Int       Date:  2021-03-25       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.